The
Search for #CBD Products – How Real Brands (OTC: $RLBD) and (NYSE: $ACB), (NYSE: $APHA), (OTC: $TGIFF) Meet Growing Demand
Point
Roberts WA, Delta BC – November1, 2019 - Investorideas.com, a
leading investor news resource covering cannabis and hemp stocks releases a
sector snapshot reporting on the growth of the CBD industry and how companies
are looking to differentiate their unique brands.
Read this in full
at https://www.investorideas.com/news/2019/cannabis/11011CBDProducts.asp
According
to a report ‘Trends in Internet
Searches for Cannabidiol (CBD) in the United States’, Google
searches for CBD are seeing exponential growth as popularity and availability
increases. ”Searches for CBD are now rivaling searches for yoga and electronic
cigarettes, with 0.96 and 0.85 of their respective search volumes, and are
searched for more than half as much as dieting.”
Another
recent
report stated, “As applications for cannabidiol are brought
to market across diverse industries such as cosmetics, health products, food
and beverage, pet products, skin care, and pharmaceuticals, the collective
market for CBD sales is expected to exceed $20 billion in the United States by
2024,” according to BDS
Analytics and Arcview Market Research.
“We’re
witnessing CBD maturing from a cannabis sub-category into a full-blown industry
of its own,” said Roy Bingham, Co-Founder and CEO of BDS Analytics. “Our growth
forecast for the CBD market, across all distribution channels, predicts a
compound annual growth rate of 49 percent by 2024. This is a great opportunity
for all involved, but it means the road ahead will include decisions that need
to be informed by the best possible data.”
As
major retailers continue to announce their stocking and private label development
of CBD products, BDS Analytics predicts that the majority of CBD product sales
will soon occur in general retail stores, rather than cannabis dispensaries, as
is currently the case. Moving forward, BDS Analytics market insights indicate
that the success of products is dependent on education and understanding,
dosing and consistent labeling.
BDS
Analytics feels CBD is in a unique position compared to other nutraceutical or
supplement ingredients for two reasons: 1) as an active ingredient in cannabis,
it has a storied history of health and wellness use and anecdotal evidence of
efficacy, and 2) it is one of the few natural remedies with scientific basis
for at least some of the claims being made about its curative powers.
Unsurprisingly, consumers are fascinated by the perceived benefits of CBD.
This
growth and drive of the CBD industry is bringing in major branding
opportunities such as sports and celebrity endorsements for each innovative
formula.
Real Brands, Inc. (OTC:
RLBD), a leading brand building company in the legal
Hemp-Derived CBD consumer products category, announced that it
has closed the previously announced acquisition of the proprietary CBD formulas
from Integrative Medicine US of Coral Springs, Florida. The formulas consist of
Ancient Chinese and other Ancient Herbal Remedies that are paired with the
latest scientific breakthroughs in endocannabinoid systems, nutrients and hemp-derived
CBD.
“We
are pleased to announce the signing of the definitive agreement to acquire
these proprietary formulas," said Real Brands, Inc. CEO, Jerry Pearring.
“Since completing our audit earlier this month, we are now focusing on
launching our brands and E-commerce website,” added Pearring. “We are
concluding the final steps in developing our unique packaging design and
formulations for each of our brands: CBD Pharmacy™, HempAid®, Humboldt Brands®
and Omegahemp™. This acquisition bolsters our efforts to offer consumers
innovative CBD products and, as we previously announced, we intend to use these
formulas for our CBD Pharmacy™ brand and feature the Chinese symbol for healing
in our new logo.”
In
addition, as part of this acquisition, Jonathan Fields, AP DOM, has entered
into an agreement to formulate additional products for Real Brands and become
the initial member of Real Brands, Inc.’s Advisory Board. “I’m pleased to
become a member of the Real Brands team and look forward to applying my
education and ongoing research into traditional eastern medical therapies to
create delivery mechanisms that act synergistically with CBD,” said Fields.
Aphria Inc. (TSX:
APHA) (NYSE:
APHA) recently
reported its results for the first quarter ended August 31,
2019, with a net revenue of $126.1 million in the first quarter, an increase of
849% from prior year quarter and a decrease of 2% from the prior quarter,
revenue for adult-use cannabis of $20.0 million in the first quarter, an
increase of 8% from the prior quarter and a net income of $16.4 million and
adjusted EBITDA of $1.0 million in the first quarter.
"We
are pleased to report a second consecutive quarter of profitable growth with
strong contribution from our Canadian cannabis operations. Our success was also
driven by our international business and the strength and growth of our brands,
particularly Broken Coast, despite a small fire at our British Columbia
facility at the end of the quarter. This solid start to the year keeps us on
track to achieve our fiscal year 2020 financial outlook," stated Irwin D.
Simon, CEO of Aphria, Inc. "Going forward, we remain focused on our
highest-return priorities both in Canada and internationally as our team
furthers the development of our medical and adult-use cannabis brands to drive
growth through innovation and return value to shareholders."
The
company, through its subsidiary Aphria
Deutschland GmbH launched their CBD-based nutraceutical, featuring CBD derived
from hemp, CannRelief. The
brand of products are being produced in the European Union and distributed by
the Company's subsidiary, CC
Pharma, which has access to more than 13,000 pharmacies
throughout Germany.
"We
are excited to introduce our first brand of CBD products for the German
nutraceutical and cosmetics market," said Jakob Ripshtein, President of
Aphria. "Supported by our extensive distribution network through CC
Pharma, CannRelief provides a natural extension to Aphria's growing business
opportunities in the German medical cannabis market. We look forward to
providing a full range of CannRelief CBD products this year."
CannRelief
CBD oils are being sold in both a 5% and 10% CBD concentration and can be found
in select stores across Germany. A range of skincare and other products,
including creams, serums and masks will be introduced under the CannRelief
brand in a phased rollout in 2019.
Aurora Cannabis
Inc.
(NYSE:
ACB)
(TSX:
ACB),
a Canadian company that's defining the future of cannabis worldwide, and the UFC, the world's premier mixed martial
arts organization, announced their
launch of a joint clinical research program that will produce multiple studies
under the terms of their recently announced partnership.
The ground-breaking
research partnership is aimed at understanding key health and recovery needs of
elite athletes in such a highly physical and competitive sport as mixed martial
arts. Research data will then be used to drive the development of
science-backed, hemp-derived CBD topicals that will be safe and reliable. These
new products will help combat the rapidly growing market of untested CBD
treatments currently being used by high-performance and non-professional
athletes.
Once research is
complete, any resulting product will come to life in the US under the new
high-performance sports brand ROAR Sports, a portfolio of high-quality,
hemp-derived CBD topical treatments scientifically formulated with elite
athletes in mind. Through analysis of athlete needs and scientific data, ROAR
Sports will challenge the status quo, seek to alleviate the stresses of
competition, and earn designation as the "Official CBD product of
UFC."
The multi-phase
clinical study at the UFC Performance Institute® in Las Vegas will
be led by Dr. Jason Dyck, Chair of Aurora's Global Scientific Oversight
Committee; Dr. Kelly Narine, Aurora's Vice President Global Research and
Medical Affairs; and the team of sports performance experts at the UFC
Performance Institute, led by Dr. Duncan French, UFC Vice President of
Performance. Using active UFC athletes on a strictly voluntary basis, the study
will help establish peer-reviewed, publishable research in this area. Products
will be developed in full compliance with U.S. federal law and with UFC's
anti-doping program, which adheres to WADA and USADA regulations.
"Our
partnership with UFC is about committing to the science that will educate and
advocate," said Aurora CEO, Terry Booth. "We are going to work
together to change the way people think, to change the industry, and to launch
the first hemp-derived CBD products that are backed by scientific research. The
brand-building and product development are all part of our move into the U.S.,
and in collaboration with UFC, and we intend to play a major role in that market."
"We know
anecdotally that professional athletes across sports disciplines are turning to
hemp-derived CBD treatments to assist with physical recovery, with varying
degrees of success," added Jason Dyck, Chair of Aurora's Global Scientific
Oversight Committee. "The work we do in partnership with UFC will create
an evidence-based, science-backed pipeline of consistent, and 'clean'
hemp-derived CBD topicals that the high-performance athletes of UFC can rely on
to treat the pain, inflammation, injury and other conditions associated with
competing at such a high level."
"Collaborating
with Aurora is the best way to educate ourselves and our fighters about the
impact of CBD on MMA athletes and our sport," said Dr. Duncan French,
UFC's Vice President of Performance. "We want to apply science and see
where it leads us. Ideally, these
studies will give us the clarity we need to determine the effectiveness of
hemp-derived CBD on athlete health and injury recovery."
"Although CBD
is allowed under USADA and WADA regulations, we want to be the leaders on
educating UFC athletes on CBD use," said Jeff Novitzky, UFC Senior Vice
President of Athlete Health & Performance. "Athlete safety is a top
priority for UFC, and we will collaborate with Aurora to ensure that any new
products are third-party tested for all WADA-prohibited substances to make
certain they meet WADA standards."
1933 Industries
Inc. (CSE:
TGIF) (OTC:
TGIFF), a vertically integrated cannabis consumer packaged
goods company, recently
announced that it will introduce its newest product, the
Birdhouse CBD Balm by Canna Hemp X™, on November 4th, 2019. The CBD
Balm was developed in collaboration with Birdhouse Skateboards™, targeting the
action sports market and will be available for sale in dispensaries, wellness
stores, skate shops and specialty retailers, including Zumiez in the United
States.
Focusing
on the wellness market through the creation of innovative products that enhance
and improve people's lives, the Company's CBD-infused line is nationally
recognized for its quality and purity of ingredients. Building on its already
successful Canna Hemp X™ brand, the new Birdhouse CBD Balm is a must-have for
any athlete in need of fast results before, during, and after exercise. The
quick-acting Birdhouse CBD Balm is specially formulated with a blend of
essential oils, arnica, peppermint, menthol and other natural ingredients. With
broad-spectrum CBD, all Canna Hemp™ products are nanoparticulated to ensure
total transdermal absorption for maximum effects, while being 100% THC-free.
The
sports world is fast embracing the use of cannabidiol or CBD, one of over 100
non-psychoactive and non-addictive compounds extracted from the cannabis plant,
in a variety of new products aimed at enhancing performance and recovery. Pro
and amateur athletes are now advocating CBD as an alternative to opioid use.
"We are just starting to scratch the surface of the many applications
associated with the cannabis plant and we are pleased to be part of a national
conversation about its potential. The anecdotal benefits keep mounting and we
believe that this market is underserved," commented Mr. Chris Rebentisch,
1933 Industries CEO.
He
added, "We constantly improve our formulations through research and we
worked closely with the Birdhouse team over several months to develop a
next-generation CBD topical product that would have wide appeal in the sports
world. We are pleased to unveil the Birdhouse CBD Balm that both companies are
proud to endorse."
Internationally
recognized skateboarding legend Mr. Tony Hawk, Founder of Birdhouse
Skateboards™ said, "The Birdhouse CBD Balm is our first collaboration with
the team at Canna Hemp X™ and was created with skateboarders and athletes of
all levels in mind. Sports like skateboarding require the highest quality
recovery products to sustain longevity. We also hope to create awareness of the
potential of CBD and in making natural products more accessible
nationwide."
As
this CBD industry continues to grow, in many ways almost independent of the
cannabis sector, brand awareness will become essential as consumers gain more
familiarity and awareness of the Hemp/CBD space. As one recent news piece put
it, “CBD
now has ‘a life of its own’”, and it will be the companies able
to build their brands out early through sponsorship agreements, as well as show
consistent quality of their innovative formulas that will stand ahead of the
rest.
About Investorideas.com - News that
Inspires Big Investing Ideas Investorideas.com
is a recognized news source publishing third party news, research and original
financial content. Learn about investing in stocks and sector trends with our
news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining,
sports biotech, water, renewable energy and more. Investor Idea’s original
branded content includes the following podcasts and columns : Crypto
Corner , Play by Play
sports and stock news column, Investor
Ideas Potcasts Cannabis
News and Stocks on the Move podcast and column, Cleantech and Climate Change , Exploring Mining, the AI Eye .
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles
and equity research as well as creates original content, including video,
interviews and articles. Original content created by investorideas is protected
by copyright laws other than syndication rights. Our site does not make
recommendations for purchases or sale of stocks, services or products. Nothing
on our sites should be construed as an offer or solicitation to buy or sell
products or securities. All investing involves risk and possible losses of all
investment. This site is currently compensated for news publication and
distribution, social media and marketing, content creation and more. Disclosure
is posted for each compensated news release, content published /created if
required but otherwise the news was not compensated for and was published for
the sole interest of our readers and followers. Contact management and IR of
each company directly regarding specific questions. Disclosure: this
news article featuring Real Brands, Inc. RLBD is a paid for news release on
Investorideas.com – third party (two thousand) More
disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other
news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and
tickertagstocknews.com
Global investors must adhere to regulations of each country.
Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Follow us on Social Media
Contact Investorideas.com
800-665-0411
